• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

CP-547632 Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5752947

CP-547632 is a well-tolerated, orally-bioavailable inhibitor of the VEGFR-2 and basic fibroblast growth factor (FGF) kinases (IC50s: 11nM and 9nM) with antitumor efficacy. More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
CP-547632, Inhibitor
Full Product Name
CP-547632
Product Gene Name
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
532.4
Solubility
DMSO: 115mg/mL (216.00mM)
(<1mg/ml refers to the product slightly soluble or insoluble)
Formula
C20H24BrF2N5O3S
SMILES
O=C(NC1=C(C(N)=O)C(OCC2=C(F)C=C(Br)C=C2F)=NS1)NCCCCN3CCCC3
CAS Number
252003-65-9
Target & IC50
VEGFR-2: ic50 11nM
FGFR: ic50 9nM
In Vitro
CP-547632 (p.o.; 50mg/kg) yieldes plasma concentrations above 500ng/ml for 12 hours. CP-547632 (p.o.; 6.25-100mg/kg/day; for 10-24 days) causes a dose-dependent inhibition of growth in Colo-205, DLD-1, and MDA-MB-231 xenografts.

Structure of CP-547632, inhibitor

CP-547632 Inhibitor – Cat# MBS5752947

Product References and Citations for CP-547632, inhibitor

Beebe JS, et al. Pharmacological characterization of CP-547,632, a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for cancer therapy. Cancer Res. 2003 Nov 1;63(21):7301-9.
Beebe JS, et al. Pharmacological characterization of CP-547,632, a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for cancer therapy. Cancer Res. 2003 Nov 1;63(21):7301-9.

Other Notes

Small volumes of CP-547632, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for CP-547632 purchase

MBS5752947 is an inhibitor targeting CP-547632.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000